Drug discovery for malaria: a very challenging and timely endeavor.
暂无分享,去创建一个
[1] T. Shapiro,et al. Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity. , 2006, Journal of medicinal chemistry.
[2] Christian Scheurer,et al. Identification of an antimalarial synthetic trioxolane drug development candidate , 2004, Nature.
[3] David K Williams,et al. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. , 2005, Journal of medicinal chemistry.
[4] J. Derisi,et al. Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum. , 2006, Bioorganic & medicinal chemistry.
[5] P. O’Neill,et al. Knowledge of the proposed chemical mechanism of action and cytochrome p450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides. , 2004, Accounts of chemical research.
[6] Timothy S. Ham,et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.
[7] Parallel synthesis and antimalarial screening of a 4-aminoquinoline library. , 2004, Journal of combinatorial chemistry.
[8] D. Boykin,et al. CYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime] , 2006, Drug Metabolism and Disposition.
[9] P. Rathod,et al. Resistance to a Protein Farnesyltransferase Inhibitor in Plasmodium falciparum* , 2005, Journal of Biological Chemistry.
[10] I. Bathurst,et al. Medicines for Malaria Venture: sustaining antimalarial drug development. , 2006, Trends in parasitology.
[11] Solomon Nwaka,et al. Innovative lead discovery strategies for tropical diseases , 2006, Nature Reviews Drug Discovery.
[12] A. Dreisbach,et al. Randomized Dose-Ranging Controlled Trial of AQ-13, a Candidate Antimalarial, and Chloroquine in Healthy Volunteers , 2007, PLoS clinical trials.
[13] D. Boykin,et al. Accumulation and Intracellular Distribution of Antitrypanosomal Diamidine Compounds DB75 and DB820 in African Trypanosomes , 2006, Antimicrobial Agents and Chemotherapy.
[14] H. Vial,et al. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts. , 2000, Journal of medicinal chemistry.
[15] S. Krishna,et al. Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.
[16] S. Meshnick,et al. Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections. , 2005, The Journal of infectious diseases.
[17] H. Vial,et al. Prodrugs of bisthiazolium salts are orally potent antimalarials. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] Ruth H. Hughes,et al. Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. , 2003, Journal of medicinal chemistry.
[19] H. Vial,et al. A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes , 2002, Science.
[20] Angus Cameron,et al. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins , 2005, Nature Structural &Molecular Biology.
[21] S. Croft,et al. Public-private partnership: from there to here. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.